Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bio-Rad Laboratories, Inc. Class A Common Stock
(NY:
BIO
)
352.11
+10.36 (+3.03%)
Streaming Delayed Price
Updated: 11:30 AM EST, Jan 13, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Bio-Rad Laboratories, Inc. Class A Common Stock
< Previous
1
2
3
Next >
Bio-Rad and QIAGEN Announce Patent Settlement and Cross-Licensing Agreement
July 26, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Announces New Share Repurchase Program
July 20, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2023 Financial Results on Thursday, August 3, 2023
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Publishes Corporate Sustainability Report for 2022
July 10, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Present Company Overview at Jefferies Healthcare Conference
June 01, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During 2023 RBC Capital Markets Global Healthcare Conference
May 08, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports First-Quarter 2023 Financial Results
May 04, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First Quarter 2023 Financial Results on Thursday, May 4, 2023
April 12, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Citi’s 2023 Healthcare Services, MedTech, Tools & HCIT Conference
February 17, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2022 Financial Results
February 16, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Cytek® Biosciences Partners with Bio-Rad to Expand Reagent Portfolios
February 07, 2023
New Agreement Enhances High-Parameter Panels on Cytek Cell Analysis Systems
From
Cytek Biosciences, Inc.
Via
GlobeNewswire
Bio-Rad to Report Fourth Quarter and Full Year 2022 Financial Results on Thursday, February 16, 2023
January 06, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Present Company Overview at J.P. Morgan 41st Annual Healthcare Conference
January 04, 2023
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad To Participate in Fireside Chat During Credit Suisse’s 31st Annual Healthcare Conference
October 31, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2022 Financial Results
October 27, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third Quarter 2022 Financial Results on Thursday, October 27, 2022
October 17, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Acquires Curiosity Diagnostics
August 03, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Second-Quarter 2022 Financial Results
July 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Second Quarter 2022 Financial Results on Thursday, July 28, 2022
July 18, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Publishes Corporate Sustainability Report
June 27, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports First-Quarter 2022 Financial Results
April 28, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022
April 18, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Presents Growth Strategy and Acceleration of Financial Targets at Investor Day
February 25, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Fourth-Quarter and Full-Year 2021 Financial Results
February 10, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Host Investor Day on February 25
February 02, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Fourth-Quarter and Full-Year 2021 Financial Results, Thursday, February 10, 2022
January 25, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Participate in Fireside Chat During the 40th Annual J.P. Morgan Healthcare Conference on January 11
January 05, 2022
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Appoints Simon May Executive Vice President and Life Science Group President
December 16, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad Reports Third-Quarter 2021 Financial Results
October 28, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
Bio-Rad to Report Third-Quarter 2021 Financial Results, Thursday, October 28, 2021
October 15, 2021
From
Bio-Rad Laboratories, Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
